STAR logo

iStar (STAR) Stock

Profile

Full Name:

iStar Inc.

Industry:

Diversified

Country:

United States

IPO:

16 November 1989

Indexes:

Not included

Description:

iStar Inc. (NYSE: STAR) is focused on reinventing the ground lease sector, unlocking value for real estate owners throughout the country by providing modern, more efficient ground leases on all types of properties. As the founder, investment manager and largest shareholder of Safehold Inc. (NYSE: SAFE), the first publicly traded company to focus on modern ground leases, iStar is helping create a logical new approach to the way real estate is owned, and continues to use its historic strengths in finance and net lease to expand this unique platform. Recognized as a consistent innovator in the real estate markets, iStar specializes in identifying and scaling newly discovered opportunities and has completed more than $40 billion of transactions over the past two decades.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

May 03, 2023

Recent annual earnings:

Feb 21, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Aug 31, 2022
Splits

Next split:

N/A

Recent split:

Mar 31, 2023

Analyst ratings

Recent major analysts updates

31 Jan '23 Raymond James
Market Perform
24 May '22 Raymond James
Outperform
03 Nov '21 Raymond James
Outperform
10 Sept '21 Berenberg
Buy
04 Aug '21 Raymond James
Outperform
23 June '21 B. Riley Securities
Buy
25 Feb '21 Raymond James
Outperform
13 Apr '20 Raymond James
Outperform
27 Feb '20 Raymond James
Outperform
21 Oct '19 Barrington Research
Outperform

Screeners with STAR included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

ROYAL CARIBBEAN'S NEXT EDITION OF ITS ARTIST DISCOVERY PROGRAM TO SHINE ON STAR OF THE SEAS
ROYAL CARIBBEAN'S NEXT EDITION OF ITS ARTIST DISCOVERY PROGRAM TO SHINE ON STAR OF THE SEAS
ROYAL CARIBBEAN'S NEXT EDITION OF ITS ARTIST DISCOVERY PROGRAM TO SHINE ON STAR OF THE SEAS
STAR
prnewswire.com16 January 2025

The vacation brand's art program will spotlight up-and-coming Caribbean artists on Star of the Seas MIAMI , Jan. 16, 2025 /PRNewswire/ -- More ways to bring to life the heart of the Caribbean, its people, beauty and culture are on deck. Royal Caribbean announced that its " Artist Discovery Program " returns to the Caribbean, calling on brilliant artists across the region to showcase their work on the next combination of the best of every vacation,  Star of the Seas.

LIBERTY ALL-STAR® Growth Fund, Inc. Declares Distribution
LIBERTY ALL-STAR® Growth Fund, Inc. Declares Distribution
LIBERTY ALL-STAR® Growth Fund, Inc. Declares Distribution
STAR
prnewswire.com13 January 2025

BOSTON , Jan. 13, 2025 /PRNewswire/ -- The Board of Directors of Liberty All-Star Growth Fund, Inc. (NYSE: ASG) has declared a distribution of $0.12 per share payable on March 10, 2025 to shareholders of record on January 24, 2025. This distribution is in accordance with the Fund's current distribution policy of paying distributions on its shares totaling approximately 8 percent of its net asset value per year, payable in four quarterly installments of 2 percent.

Astria Therapeutics: Transformative Proof Of Concept Data In Hereditary Angioedema
Astria Therapeutics: Transformative Proof Of Concept Data In Hereditary Angioedema
Astria Therapeutics: Transformative Proof Of Concept Data In Hereditary Angioedema
STAR
seekingalpha.com27 November 2024

Astria Therapeutics, Inc.'s STAR-0215 shows 90-96% reduction in HAE attack frequency, with a twice-a-year dosing regimen, positioning it as a transformative therapy. The company has a strong cash balance of $344 million, ensuring a runway until 2027, supporting continued development and trials. Competitive positioning is strong, with STAR-0215 outperforming existing treatments like Takhzyro and Haegarda in both efficacy and dosing convenience.

PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore
PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore
PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore
STAR
globenewswire.com01 October 2024

The new lab will leverage PacBio's HiFi sequencing technology to broaden access to highly accurate long-read sequencing and multi-omics solutions in Southeast Asia The new lab will leverage PacBio's HiFi sequencing technology to broaden access to highly accurate long-read sequencing and multi-omics solutions in Southeast Asia

TOYOTA JOINS LATIN MUSIC RISING STAR, DANNY OCEAN, ON LONG-AWAITED NORTH AMERICAN MUSIC TOUR
TOYOTA JOINS LATIN MUSIC RISING STAR, DANNY OCEAN, ON LONG-AWAITED NORTH AMERICAN MUSIC TOUR
TOYOTA JOINS LATIN MUSIC RISING STAR, DANNY OCEAN, ON LONG-AWAITED NORTH AMERICAN MUSIC TOUR
STAR
prnewswire.com19 September 2024

PLANO, Texas , Sept. 19, 2024 /PRNewswire/ -- Venezuelan singer and songwriter Danny Ocean has launched his highly anticipated "Reflexa" tour across the United States and Canada, electrifying audiences with his signature energy.

ROYAL CARIBBEAN'S STAR OF THE SEAS TAKES CENTER STAGE TO DELIVER ULTIMATE FAMILY VACATION
ROYAL CARIBBEAN'S STAR OF THE SEAS TAKES CENTER STAGE TO DELIVER ULTIMATE FAMILY VACATION
ROYAL CARIBBEAN'S STAR OF THE SEAS TAKES CENTER STAGE TO DELIVER ULTIMATE FAMILY VACATION
STAR
prnewswire.com20 August 2024

Starting August 2025, the next combination of every vacation will headline Port Canaveral (Orlando), Florida, with the record-setting lineup of Icon Class experiences MIAMI , Aug. 20, 2024  /PRNewswire/ -- Royal Caribbean International's Star of the Seas will soon double the world's best vacation count in one of the world's top travel destinations, and the full lineup of unrivaled experiences in store has been revealed. From thrills like the fastest and tallest waterslides to 40-plus ways to dine and drink combined with adventures in idyllic destinations like the cruise line's Perfect Day at CocoCay in The Bahamas, the next combination of the best of every vacation sets the stage for everyone to make memories from Port Canaveral (Orlando), Florida.

Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
STAR
accesswire.com07 August 2024

- DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial has enrolled over 50% of patients - Dermata continues discussions with potential botulinum toxin partners for DMT410 - Raised $2.3 million in net proceeds from financing completed in 2Q 2024 SAN DIEGO, CA / ACCESSWIRE / August 7, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW)("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today highlighted recent corporate progress and reported financial results for the second quarter ended June 30, 2024. "We are excited to have enrolled over 50% of patients in our DMT310 Phase 3 STAR-1 trial, and we look forward to the second half of 2024 as our team continues to work diligently to complete enrollment of the DMT310 STAR-1 trial," commented Gerry Proehl, Dermata's Chairman, President, and Chief Executive Officer.

HRaspirin, Ltd. is Pleased to Announce that its Documentation Management System is in Final Testing and Customer Trials
HRaspirin, Ltd. is Pleased to Announce that its Documentation Management System is in Final Testing and Customer Trials
HRaspirin, Ltd. is Pleased to Announce that its Documentation Management System is in Final Testing and Customer Trials
STAR
accesswire.com24 July 2024

LAS VEGAS, NV / ACCESSWIRE / July 24, 2024 / Star Alliance International Corp. (OTC PINK:STAL), ("STAR or the Company"). STAR is pleased to confirm that HRaspirin is testing its new and exciting HRADocs program that offers electronic signatures plus a document management system.

CAPTAIN MORGAN SLICED AND REALITY STAR WEST WILSON 'SLICE' THROUGH SUMMER BUCKET LISTS
CAPTAIN MORGAN SLICED AND REALITY STAR WEST WILSON 'SLICE' THROUGH SUMMER BUCKET LISTS
CAPTAIN MORGAN SLICED AND REALITY STAR WEST WILSON 'SLICE' THROUGH SUMMER BUCKET LISTS
STAR
prnewswire.com22 July 2024

The newest cocktail-inspired RTD offering from America's favorite rum brand launches a nationwide sweepstakes that goes all-in on summer adventures and bold flavor NEW YORK , July 22, 2024 /PRNewswire/ -- Summer bucket lists are back, and there's one item that's topping lists nationwide

Meritage Homes Named ENERGY STAR® Partner of the Year For 11th Year & Honored for Highest Homebuyer Ratings in 21st Annual Avid Awards
Meritage Homes Named ENERGY STAR® Partner of the Year For 11th Year & Honored for Highest Homebuyer Ratings in 21st Annual Avid Awards
Meritage Homes Named ENERGY STAR® Partner of the Year For 11th Year & Honored for Highest Homebuyer Ratings in 21st Annual Avid Awards
STAR
globenewswire.com18 June 2024

The homebuilder was also recognized for its philanthropic efforts and commitment to sustainability The homebuilder was also recognized for its philanthropic efforts and commitment to sustainability

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the primary business of iStar?
  • What is the ticker symbol for iStar?
  • Does iStar pay dividends?
  • What sector is iStar in?
  • What industry is iStar in?
  • What country is iStar based in?
  • When did iStar go public?
  • Is iStar in the S&P 500?
  • Is iStar in the NASDAQ 100?
  • Is iStar in the Dow Jones?
  • When was iStar's last earnings report?
  • When does iStar report earnings?
  • Should I buy iStar stock now?

What is the primary business of iStar?

iStar Inc. (NYSE: STAR) is focused on reinventing the ground lease sector, unlocking value for real estate owners throughout the country by providing modern, more efficient ground leases on all types of properties. As the founder, investment manager and largest shareholder of Safehold Inc. (NYSE: SAFE), the first publicly traded company to focus on modern ground leases, iStar is helping create a logical new approach to the way real estate is owned, and continues to use its historic strengths in finance and net lease to expand this unique platform. Recognized as a consistent innovator in the real estate markets, iStar specializes in identifying and scaling newly discovered opportunities and has completed more than $40 billion of transactions over the past two decades.

What is the ticker symbol for iStar?

The ticker symbol for iStar is NYSE:STAR

Does iStar pay dividends?

No, iStar does not pay dividends

What sector is iStar in?

iStar is in the Real Estate sector

What industry is iStar in?

iStar is in the Diversified industry

What country is iStar based in?

iStar is headquartered in United States

When did iStar go public?

iStar's initial public offering (IPO) was on 16 November 1989

Is iStar in the S&P 500?

No, iStar is not included in the S&P 500 index

Is iStar in the NASDAQ 100?

No, iStar is not included in the NASDAQ 100 index

Is iStar in the Dow Jones?

No, iStar is not included in the Dow Jones index

When was iStar's last earnings report?

iStar's most recent earnings report was on 3 May 2023

When does iStar report earnings?

The date for iStar's next earnings report has not been announced yet

Should I buy iStar stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions